• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo.

作者信息

Burkhoff D, Shemer I, Felzen B, Shimizu J, Mika Y, Dickstein M, Prutchi D, Darvish N, Ben-Haim S A

机构信息

Divisions of Circulatory Physiology and Cardiology, Cardiac Physiology Laboratory, Department of Medicine, Columbia University, NY, USA.

出版信息

Heart Fail Rev. 2001 Jan;6(1):27-34. doi: 10.1023/a:1009851107189.

DOI:10.1023/a:1009851107189
PMID:11248765
Abstract
摘要

相似文献

1
Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo.
Heart Fail Rev. 2001 Jan;6(1):27-34. doi: 10.1023/a:1009851107189.
2
Global improvement in left ventricular performance observed with cardiac contractility modulation is the result of changes in regional contractility.通过心脏收缩力调制观察到的左心室功能的整体改善是局部收缩力变化的结果。
Heart Fail Rev. 2001 Jan;6(1):35-44. doi: 10.1023/a:1009803224027.
3
Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs.非兴奋性心脏收缩力调制电信号对犬心力衰竭进展的长期影响。
Eur J Heart Fail. 2004 Mar 1;6(2):145-50. doi: 10.1016/j.ejheart.2003.11.001.
4
Effects of electric stimulations applied during absolute refractory period on cardiac function of rabbits with heart failure.绝对不应期施加电刺激对心力衰竭家兔心脏功能的影响。
J Huazhong Univ Sci Technolog Med Sci. 2010 Apr;30(2):155-8. doi: 10.1007/s11596-010-0204-3. Epub 2010 Apr 21.
5
Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure.心脏收缩力的电调制：充血性心力衰竭的临床方面
Heart Fail Rev. 2001 Jan;6(1):55-60. doi: 10.1023/a:1009807309006.
6
Electrical modulation of cardiac contractility in heart failure: the impulse dynamics signal. Editor's overview.
Heart Fail Rev. 2001 Jan;6(1):5-6. doi: 10.1023/a:1009877622210.
7
Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure.基于冲动动力学信号的心脏收缩力调制：对慢性心力衰竭犬的研究
Heart Fail Rev. 2001 Jan;6(1):45-53. doi: 10.1023/a:1009855208097.
8
Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-β1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure.心脏收缩力调制通过抑制慢性心力衰竭兔模型中的TGF-β1/Smad3信号通路减轻心肌纤维化。
Cell Physiol Biochem. 2016;39(1):294-302. doi: 10.1159/000445624. Epub 2016 Jun 27.
9
A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.心力衰竭患者每天接受5小时与12小时心脏收缩力调制治疗的随机对照比较：初步报告。
Cardiol J. 2016;23(1):114-9. doi: 10.5603/CJ.a2015.0073. Epub 2015 Oct 27.
10
Anaesthesia and cardiac contractility modulation.麻醉与心脏收缩力调节
Eur J Anaesthesiol. 2007 Oct;24(10):819-25. doi: 10.1017/S0265021507000853. Epub 2007 Jun 20.

引用本文的文献

1
"Optimizing" the Anesthetic for Cardiac Contractility Modulation Devices.优化用于心脏收缩力调节装置的麻醉
J Innov Card Rhythm Manag. 2025 Mar 15;16(3):6223-6228. doi: 10.19102/icrm.2025.16032. eCollection 2025 Mar.
2
Device-therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy.慢性心力衰竭的器械治疗：心脏收缩力调制与心脏再同步治疗
ESC Heart Fail. 2025 Feb;12(1):456-466. doi: 10.1002/ehf2.15067. Epub 2024 Sep 29.
3
Cardiac Contractility Modulation for Heart Failure: Current and Future Directions.

本文引用的文献

1
Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay.扩张型心肌病合并室内传导延迟患者左心室预激导致收缩期增强的预测因素。
Circulation. 2000 Jun 13;101(23):2703-9. doi: 10.1161/01.cir.101.23.2703.
2
Inotropes in the beta-blocker era.β受体阻滞剂时代的正性肌力药物
Clin Cardiol. 2000 Mar;23(3 Suppl):III11-6. doi: 10.1002/clc.4960231504.
3
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
心力衰竭的心脏收缩力调制：现状与未来方向。
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101176. doi: 10.1016/j.jscai.2023.101176. eCollection 2023 Nov-Dec.
4
Cardiac contractility modulation in patients with heart failure - A review of the literature.心力衰竭患者的心脏收缩力调节——文献综述。
Heart Fail Rev. 2024 May;29(3):689-705. doi: 10.1007/s10741-024-10390-1. Epub 2024 Feb 23.
5
Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models.心脏收缩力调制刺激在传统二维和三维人诱导多能干细胞衍生心肌细胞模型中的急性效应。
Front Physiol. 2022 Nov 10;13:1023563. doi: 10.3389/fphys.2022.1023563. eCollection 2022.
6
Human in vitro neurocardiac coculture (ivNCC) assay development for evaluating cardiac contractility modulation.人离体神经心肌共培养（ivNCC）检测方法的开发，用于评估心脏收缩力调节。
Physiol Rep. 2022 Nov;10(21):e15498. doi: 10.14814/phy2.15498.
7
The Effects of Device-Based Cardiac Contractility Modulation Therapy on Left Ventricle Global Longitudinal Strain and Myocardial Mechano-Energetic Efficiency in Patients with Heart Failure with Reduced Ejection Fraction.基于设备的心脏收缩力调制疗法对射血分数降低的心力衰竭患者左心室整体纵向应变和心肌机械能效率的影响。
J Clin Med. 2022 Oct 4;11(19):5866. doi: 10.3390/jcm11195866.
8
Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.心肌收缩调节对人诱导多能干细胞衍生心肌细胞的急性影响。
Physiol Rep. 2021 Nov;9(21):e15085. doi: 10.14814/phy2.15085.
9
Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction.心脏收缩力调制用于治疗射血分数降低的心力衰竭。
Heart Fail Rev. 2021 Mar;26(2):217-226. doi: 10.1007/s10741-020-10017-1. Epub 2020 Aug 27.
10
Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.心脏收缩力调节治疗的结果：随机临床试验的系统评价和荟萃分析。
Cardiovasc Ther. 2019 Jun 17;2019:9769724. doi: 10.1155/2019/9769724. eCollection 2019.
控释美托洛尔对心力衰竭患者总死亡率、住院率及健康状况的影响：美托洛尔控释/缓释片在充血性心力衰竭中的随机干预试验（MERIT-HF）。MERIT-HF研究组
JAMA. 2000 Mar 8;283(10):1295-302. doi: 10.1001/jama.283.10.1295.
4
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.螺内酯对重度心力衰竭患者发病率和死亡率的影响。随机螺内酯评估研究调查组。
N Engl J Med. 1999 Sep 2;341(10):709-17. doi: 10.1056/NEJM199909023411001.
5
Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group.起搏腔室及房室延迟对充血性心力衰竭起搏患者急性收缩功能的影响。充血性心力衰竭起搏治疗研究组。Guidant充血性心力衰竭研究组。
Circulation. 1999 Jun 15;99(23):2993-3001. doi: 10.1161/01.cir.99.23.2993.
6
Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay.扩张型心肌病合并心室传导延迟患者急性VDD起搏可改善左心室力学功能。
Circulation. 1999 Mar 30;99(12):1567-73. doi: 10.1161/01.cir.99.12.1567.
7
Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure.实验性心肌肥厚和心力衰竭中兴奋-收缩偶联缺陷
Science. 1997 May 2;276(5313):800-6. doi: 10.1126/science.276.5313.800.
8
The effect of digoxin on mortality and morbidity in patients with heart failure.地高辛对心力衰竭患者死亡率和发病率的影响。
N Engl J Med. 1997 Feb 20;336(8):525-33. doi: 10.1056/NEJM199702203360801.
9
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.卡维地洛对中重度心力衰竭患者影响的双盲、安慰剂对照研究。PRECISE试验。卡维地洛对症状和运动影响的前瞻性随机评估。
Circulation. 1996 Dec 1;94(11):2793-9. doi: 10.1161/01.cir.94.11.2793.
10
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.卡维地洛对慢性心力衰竭患者发病率和死亡率的影响。美国卡维地洛心力衰竭研究组。
N Engl J Med. 1996 May 23;334(21):1349-55. doi: 10.1056/NEJM199605233342101.